Lyme Disease
📧 Sign up to get email alerts when something new happens for Lyme Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Doxycycline in Therapy of Erythema Migrans
A clinical trial evaluating doxycycline for erythema migrans (Lyme disease) has completed.
-
FDA approval · 2015-09-21FDA Approved: DOXYCYCLINE HYCLATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Doxycycline Hyclate by Hikma Pharmaceuticals USA Inc., indicating a change to the product's labe…
-
CLINICAL_TRIALS trial_result · 2015-06-30Clinical Trial Update: Culture Media for Borrelia Burgdorferi Sensu Lato [NA]
The study reports results posted in 2015 for culture media used to grow Borrelia burgdorferi sensu lato in patients with erythema migrans (L…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice [Phase 4]
Phase 4 trial comparing three antibiotic regimens for erythema migrans has completed in general practice. The study was sponsored by Morten …
-
FDA approval · 2014-03-05FDA Approved: DOXYCYCLINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' generic doxycycline (DOXYCYCLINE) under an original application.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Lyme Disease Prevention Program [Phase 3]
A Phase 3 trial evaluating a Lyme disease prevention program has completed, sponsored by Brigham and Women's Hospital.
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Duration of Antibiotic Treatment of Erythema Migrans [NA]
A completed clinical trial evaluated the duration of antibiotic treatment for erythema migrans (Lyme disease) with results posted in 2012.
-
FDA approval · 2012-04-25FDA Approved: DOXYCYCLINE HYCLATE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
The FDA approved a supplemental application for doxycycline hyclate from Chartwell Governmental & Specialty RX, LLC, confirming regulatory s…
-
CLINICAL_TRIALS trial_result · 2012-01-25Clinical Trial Update: Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome [Phase 4]
A Phase 4 trial comparing doxycycline and cefuroxime axetil for erythema migrans (Lyme disease) assessed clinical and microbiological outcom…
-
CLINICAL_TRIALS research · 2011-07-26Clinical Trial Update: The Phenomenon of "Chronic Lyme"; an Observational Study
An observational study investigating Chronic Lyme Borreliosis, sponsored by Sorlandet Hospital HF.
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation [Phase 1, Phase 2]
This trial update reports safety outcomes and pharmacokinetic data (skin and plasma concentrations) for a dermal formulation of azithromycin…
-
CLINICAL_TRIALS trial_result · 2010-09-20Clinical Trial Update: Effects of Doxycycline on Persistent Symptoms Post-neuroborreliosis [NA]
A completed clinical trial from Linkoeping University evaluating whether doxycycline improves persistent symptoms after neuroborreliosis, in…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease [Phase 3]
This trial update notes the completion of a Phase 3 randomized, double-blind, placebo-controlled multicenter trial. It evaluated the safety …
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Study and Treatment of Post Lyme Disease (STOP-LD) [Phase 3]
The STOP-LD Phase 3 trial investigating antibiotic treatment for post-Lyme disease syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease [Phase 3]
Phase 3 randomized, double-blind, placebo-controlled multicenter trial evaluating the safety and efficacy of ceftriaxone and doxycycline for…